Skip to content

London clinic reports rising cases of sexually transmitted hepatitis C

AIDS Treatment Update marks ten years

Once daily fos-amprenavir equal to nelfinavir

How common is lipodystrophy in people who have never taken HIV protease inhibitors?

Lipodystrophy has uneven impact on quality of life, says study

South African report says 9% of all deaths caused by HIV

PI and NNRTI based regimens equally effective in treating KS, says study

Skeletal muscle damage: emerging toxicity of HIV therapy?

Tenofovir/ddI interaction: pancreatitis death highlights risk

Ritonavir highest risk HIV protease inhibitor for lipid rises

Thymidine analogue mutations rare in first-line HAART failure

3TC treatment preserves and promotes NNRTI resistance

Risk factors for heart disease widespread among HIV patients

AIDS causing famine, undermining political stability, says UNAIDS

Herpes suppression leads to lower HIV viral load, says study

Atazanavir early access: now available through 20 UK HIV clinics

WHO surveys AIDS treatment access, highlights health gap seen by UNAIDS

UNAIDS reveals latest statistics: 5 million new HIV cases in 2002